02-10-2020  Bioharmony Therapeutics CEO discussing AMR and the need for novel antimicrobials.


09-04-2019  Our partnership with Boehringer Ingelheim to address AMR. 
















09-04-2019   Bioharmony Therapeutics to present a pipeline overview at the ASM-ESCMID Conference 2019 in Boston.

08-01-2019   Bioharmony Therapeutics featured as Life Science Leaders Companies to Watch.


02-08-2019   Bioharmony Therapeutics to present a pipeline overview at the Superbugs & Superdrugs 2019 Conference in London on March 18th, 2019 

01-29-2019    Bioharmony Therapeutics to present a pipeline overview at the Phage Futures Conference in Washington, D.C on January 30th, 2019. 

01-16-2019 Bioworld featuring Bioharmony Therapeutics.


01-15-2019  Bioharmony Therapeutics and Boehringer Ingelheim Collaborate to Advance Bacteriophage Lysin Therapeutics for the Treatment of Multi-Drug Resistant Bacterial Infections


07-19-2018   Chandra Ghose has been selected to be part of the Aspen Global Leadership Network as a Fellow of the Aspen Institute’s fourth class of Health Innovators Fellows.  


03-15-2018  Healthcare finalist Bioharmony Therapeutics pitches at the 2017 Hello Tomorrow Challenge Finals in Paris on Oct 26-27th,  2017.



02-20-2018  Bioharmony Therapeutics featured in French media


12-18-2017   Accelerate NY Seed Fund Awards Bioharmony Therapeutics $100,000 to Develop a Lysin-based Treatment for Skin Infections Caused by Multi-drug Resistant Acinetobacter baumanii


12-17-2017  Bioharmony Therapeutics in the news.


11-15-2017  Bioharmony Therapeutics wins second place at RESI Innovation Challenge in NYC.


10-20-2017  Bioharmony Therapeutics to present at the RESI New York 2017 in NYC  on November 15, 2017 .  Please come and see us pitch at the Innovation Challenge.

09-15-2017  Bioharmony Therapeutics to present at the 2017 Life Sciences Summit 2017 in NYC  on November 1-2, 2017 .  

09-05-2017  We are excited to announce that we have been selected as a Healthcare Track Finalist in the 2017 #HTChallenge! @HelloTomorrow has reviewed 3,000 applications, selected the TOP 500 deep tech startups from around the globe, and now has chosen 7 of the most innovative projects in the Healthcare sector- which includes us! You can meet us and hear us pitch at the #HTSummit in Paris to discover what we do!

06-01-2017  Bioharmony Therapeutics to present at the NY Life Science Innovation Showcase 2017 in NYC  on June 13, 2017.

05-01-2017  Bioharmony Therapeutics to present at the NewYorkBio Annual Conference in NYC  on May 10, 2017.

04-01-2017  Bioharmony Therapeutics to present at the ELabNYC Pitch Day in NYC on April 6, 2017.

01-01-2017  Bioharmony Therapeutics has been chosen to be part of The Bio & Health Entrepreneurship Lab NYC class of 2017.